Cargando…
The lack of K13-propeller mutations associated with artemisinin resistance in Plasmodium falciparum in Democratic Republic of Congo (DRC)
Artemisinin-based combination therapies (ACTs) have been recommended by the World Health Organization (WHO) as first-line treatment of uncomplicated Plasmodium falciparum (P. falciparum) malaria since 2005 in Democratic Republic of Congo (DRC) and a regular surveillance of the ACT efficacy is requir...
Autores principales: | Yobi, Doudou Malekita, Kayiba, Nadine Kalenda, Mvumbi, Dieudonné Makaba, Boreux, Raphael, Bontems, Sebastien, Kabututu, Pius Zakayi, De Mol, Patrick, Speybroeck, Niko, Mvumbi, Georges Lelo, Hayette, Marie-Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446852/ https://www.ncbi.nlm.nih.gov/pubmed/32822392 http://dx.doi.org/10.1371/journal.pone.0237791 |
Ejemplares similares
-
Care-seeking behaviour and socio-economic burden associated with uncomplicated malaria in the Democratic Republic of Congo
por: Kayiba, Nadine Kalenda, et al.
Publicado: (2021) -
The landscape of drug resistance in Plasmodium falciparum malaria in the Democratic Republic of Congo: a mapping systematic review
por: Kayiba, Nadine Kalenda, et al.
Publicado: (2023) -
Assessment of Plasmodium falciparum anti-malarial drug resistance markers in pfk13-propeller, pfcrt and pfmdr1 genes in isolates from treatment failure patients in Democratic Republic of Congo, 2018–2019
por: Yobi, Doudou M., et al.
Publicado: (2021) -
Biennial surveillance of Plasmodium falciparum anti-malarial drug resistance markers in Democratic Republic of Congo, 2017 and 2019
por: Yobi, Doudou M., et al.
Publicado: (2022) -
Molecular surveillance of anti-malarial drug resistance in Democratic Republic of Congo: high variability of chloroquinoresistance and lack of amodiaquinoresistance
por: Yobi, Doudou M., et al.
Publicado: (2020)